In the British Medical Journal, Katherine Pettus argues that because of policies to prevent illicit drug use, patients in most of the world lack palliative care and suffer severe untreated pain.
Michel Kazatchkine, UN secretary general special envoy on HIV/AIDS in Eastern Europe and Central Asia, argues that prohibition can prevent access to harm reduction treatment, including methadone, for people who inject drugs.
The USA National Academy of Science provides a comprehensive review of scientific evidence related to the health effects of cannabis and puts forward a research agenda that outlines gaps in current knowledge and opportunities for insight.
The results of an EMCDDA study on national drug trafficking laws and their application in the European Union. The penalties set out in national laws for trafficking are compared with the expected sentencing outcomes, including the estimated time to be spent in prison.
In recent years Latin American countries have increasingly rejected the traditional prohibitionist paradigm of drug policy. This paper investigates public support for these novel policies.
Transform argue that a substantial body of evidence demonstrating the effectiveness of heroin-assisted treatment provides useful lessons for managing drug use as a public health challenge and suggests the potential benefits of expanding this type of treatment.
Marie Nougier (IDPC) examines the history of the provision of harm reduction arguing for the need to redefine harm reduction beyond the provision of services and towards political and legislative reforms.
This report explores the governance dynamics surrounding the 2016 UNGASS and focuses on the Latin American perspective of the Special Session and global drug policy.
It has been a highly eventful and busy year for IDPC, not least because of UNGASS 2016. We hope that you will enjoy reading this latest progress report that gives an overview of our activities and key achievements during the period April 2015 to March 2016.
